Items where Author is "Albrich, W. C."

Yes

Conca, A. and Bossart, R. and Regez, K. and Schild, U. and Wallimann, G. and Schweingruber, R. and Hantikainen, V. and Tobias, P. and Albrich, W. C. and Rüegger, K. and Dusemund, F. and Bürgi, U. and Sigrist, T. and Mariacher-Gehler, S. and Huber, A. and Schütz, P. and Müller, B. and Reutlinger, B.. (2015) Optimized Patient Transfer through Innovative Multidisciplinary Assessment: Project Description of Phase I. Journal of Nursing and Care, 5 (1). pp. 316-322.

Drozdov, D. and Schwarz, S. and Kutz, A. and Grolimund, E. and Rast, A. C. and Steiner, D. and Regez, K. and Schild, U. and Guglielmetti, M. and Conca, A. and Reutlinger, B. and Ottiger, C. and Buchkremer, F. and Haubitz, S. and Blum, C. and Huber, A. and Buergi, U. and Schuetz, P. and Bock, A. and Fux, C. A. and Mueller, B. and Albrich, W. C.. (2015) Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial. BMC Medicine, 13. p. 104.

Albrich, W. C. and Madhi, S. A. and Adrian, P. V. and van Niekerk, N. and Telles, J. N. and Ebrahim, N. and Messaoudi, M. and Paranhos-Baccala, G. and Giersdorf, S. and Vernet, G. and Mueller, B. and Klugman, K. P.. (2014) Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia. BMJ Open, 4 (8). e005953.

Schuetz, P. and Litke, A. and Albrich, W. C. and Mueller, B.. (2013) Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Current Opinion in Infectious Diseases, 26 (2). pp. 159-167.

Schuetz, P. and Haubitz, S. and Christ-Crain, M. and Albrich, W. C. and Zimmerli, W. and Mueller, B. and Pro, Hosp Study Group. (2013) Hyponatremia and anti-diuretic hormone in Legionnaires' disease. BMC Infectious Diseases, 13. p. 585.

Dusemund, F. and Bucher, B. and Meyer, S. and Thomann, R. and Kuhn, F. and Bassetti, S. and Sprenger, M. and Baechli, E. and Sigrist, T. and Schwietert, M. and Amin, D. and Hausfater, P. and Carre, E. and Schuetz, P. and Gaillat, J. and Regez, K. and Bossart, R. and Schild, U. and Muller, B. and Albrich, W. C. and Pro, Real Study Team. (2013) Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. European Journal of Clinical Microbiology & Infectious Diseases, 32 (1). pp. 51-60.

Drozdov, D. and Thomer, A. and Meili, M. and Schwarz, S. and Kouegbe, R. B. and Regez, K. and Guglielmetti, M. and Schild, U. and Conca, A. and Schafer, P. and Reutlinger, B. and Ottiger, C. and Buchkremer, F. and Litke, A. and Schuetz, P. and Huber, A. and Burgi, U. and Fux, C. A. and Bock, A. and Muller, B. and Albrich, W. C. and Triple, P. study group. (2013) Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections - 'triple p in uti': study protocol for a randomized controlled trial. Trials, 14. p. 84.

Litke, A. and Bossart, R. and Regez, K. and Schild, U. and Guglielmetti, M. and Conca, A. and Schafer, P. and Reutlinger, B. and Mueller, B. and Albrich, W. C.. (2013) The potential impact of biomarker-guided triage decisions for patients with urinary tract infections. Infection, 41 (4). pp. 799-809.

Albrich, W. C. and Dusemund, F. and Bucher, B. and Meyer, S. and Thomann, R. and Kuhn, F. and Bassetti, S. and Sprenger, M. and Bachli, E. and Sigrist, T. and Schwietert, M. and Amin, D. and Hausfater, P. and Carre, E. and Gaillat, J. and Schuetz, P. and Regez, K. and Bossart, R. and Schild, U. and Mueller, B. and Pro, Real Study Team. (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). JAMA Internal Medicine, 172 (9). pp. 715-722.

Dusemund, F. and Steiner, M. and Vuilliomenet, A. and Muller, C. and Bossart, R. and Regez, K. and Schild, U. and Conca, A. and Huber, A. and Reutlinger, B. and Muller, B. and Albrich, W. C.. (2012) Multidisciplinary Assessment to Personalize Length of Stay in Acute Decompensated Heart Failure (OPTIMA II ADHF). Journal of Clinical Medicine Research, 4 (6). pp. 402-409.

Hartmann, O. and Schuetz, P. and Albrich, W. C. and Anker, S. D. and Mueller, B. and Schmidt, T.. (2012) Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection. International Journal of Cardiology, 161 (3). pp. 166-173.

Schuetz, P. and Haubitz, S. and Albrich, W. C. and Muller, B.. (2012) Weniger ist mehr: Indivitualisierte Antibiotika Therapie durch Messung von Procalcitonin. Swiss Medical Forum, 12 (46). pp. 887-892.

Albrich, W. C. and Muller, B. and für das ProReal study team, . (2012) Wirksamkeit und Sicherheit der Procalcitonin-gesteuerten Antibiotikatherapie bei Infekten der unteren Atemwege: Einsichten in die internationale, multizentrische Poststudy-Surveillance (ProREAL). Der Mikrobiologe, 22. pp. 83-88.

Albrich, W. C. and Ruegger, K. and Dusemund, F. and Bossart, R. and Regez, K. and Schild, U. and Conca, A. and Schuetz, P. and Sigrist, T. and Huber, A. and Reutlinger, B. and Muller, B.. (2011) Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Medical Weekly, 141. w13237.